1,2-dimethylhydrazine multiple interactions ISO RGD:1557796 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP6AP2 mRNA CTD PMID:22206623 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1557796 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1557796 6480464 Tetrachlorodibenzodioxin affects the expression of ATP6AP2 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP6AP2 mRNA CTD PMID:34747641 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ATP6AP2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1346001 6480464 Lactic Acid results in decreased expression of ATP6AP2 mRNA CTD PMID:30851411 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ATP6AP2 mRNA CTD PMID:28522335 4,4'-diaminodiphenylmethane increases expression ISO RGD:1557796 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ATP6AP2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1346001 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of ATP6AP2 gene CTD PMID:31601247 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of ATP6AP2 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of ATP6AP2 mRNA CTD PMID:19483382 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ATP6AP2 mRNA CTD PMID:24780913 7,12-dimethyltetraphene affects expression ISO RGD:1557796 6480464 9 more ... CTD PMID:21785161 acrolein multiple interactions ISO RGD:1346001 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP6AP2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATP6AP2 mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ATP6AP2 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:1346001 6480464 Aflatoxin B1 results in increased expression of ATP6AP2 mRNA CTD PMID:21641981 aldehydo-D-glucose multiple interactions EXP 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 mRNA], N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 protein] CTD PMID:19861503 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of ATP6AP2 mRNA, Glucose results in increased expression of ATP6AP2 protein CTD PMID:19861503 alpha-pinene multiple interactions ISO RGD:1346001 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP6AP2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATP6AP2 mRNA CTD PMID:32699268 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of ATP6AP2 mRNA CTD PMID:19483382 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of ATP6AP2 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO RGD:1346001 6480464 aristolochic acid I results in decreased expression of ATP6AP2 mRNA CTD PMID:33212167 arsenite(3-) increases methylation ISO RGD:1346001 6480464 arsenite results in increased methylation of ATP6AP2 promoter CTD PMID:23974009 auramine O increases expression ISO RGD:1346001 6480464 Benzophenoneidum results in increased expression of ATP6AP2 protein CTD PMID:28722353 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of ATP6AP2 mRNA CTD PMID:19483382 benzo[a]pyrene affects expression ISO RGD:1557796 6480464 Benzo(a)pyrene affects the expression of ATP6AP2 mRNA CTD PMID:22342234 benzo[a]pyrene affects methylation ISO RGD:1346001 6480464 Benzo(a)pyrene affects the methylation of ATP6AP2 promoter CTD PMID:27901495 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ATP6AP2 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1346001 6480464 bisphenol A results in increased expression of ATP6AP2 protein CTD PMID:33376534 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP6AP2 mRNA CTD PMID:34947998 C60 fullerene affects expression EXP 6480464 fullerene C60 affects the expression of ATP6AP2 mRNA CTD PMID:19167457 cadmium dichloride increases expression ISO RGD:1557796 6480464 Cadmium Chloride results in increased expression of ATP6AP2 mRNA CTD PMID:30030080 carbon nanotube increases expression ISO RGD:1557796 6480464 Nanotubes, Carbon analog results in increased expression of ATP6AP2 mRNA CTD PMID:25554681 celecoxib affects expression ISO RGD:1557796 6480464 Celecoxib affects the expression of ATP6AP2 mRNA CTD PMID:20562220 chlordecone increases expression ISO RGD:1557796 6480464 Chlordecone results in increased expression of ATP6AP2 mRNA CTD PMID:29980752 chloropicrin affects expression ISO RGD:1346001 6480464 chloropicrin affects the expression of ATP6AP2 mRNA CTD PMID:26352163 cisplatin affects response to substance ISO RGD:1346001 6480464 ATP6AP2 mRNA affects the susceptibility to Cisplatin CTD PMID:18610736 cisplatin increases expression ISO RGD:1346001 6480464 Cisplatin results in increased expression of ATP6AP2 mRNA CTD PMID:27392435 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of ATP6AP2 mRNA CTD PMID:19483382 cobalt dichloride increases expression ISO RGD:1346001 6480464 cobaltous chloride results in increased expression of ATP6AP2 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1557796 6480464 MT1 affects the reaction [Copper results in increased expression of ATP6AP2 mRNA], MT2 affects the reaction [Copper results in increased expression of ATP6AP2 mRNA] CTD PMID:16629173 copper(0) multiple interactions ISO RGD:1557796 6480464 MT1 affects the reaction [Copper results in increased expression of ATP6AP2 mRNA], MT2 affects the reaction [Copper results in increased expression of ATP6AP2 mRNA] CTD PMID:16629173 D-glucose increases expression EXP 6480464 Glucose results in increased expression of ATP6AP2 mRNA, Glucose results in increased expression of ATP6AP2 protein CTD PMID:19861503 D-glucose multiple interactions EXP 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 mRNA], N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 protein] CTD PMID:19861503 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of ATP6AP2 mRNA CTD PMID:23914054 dexamethasone decreases expression ISO RGD:1346001 6480464 Dexamethasone results in decreased expression of ATP6AP2 mRNA CTD PMID:19853017 dicrotophos decreases expression ISO RGD:1346001 6480464 dicrotophos results in decreased expression of ATP6AP2 mRNA CTD PMID:28302478 doxorubicin increases expression ISO RGD:1346001 6480464 Doxorubicin results in increased expression of ATP6AP2 mRNA CTD PMID:29803840 epoxiconazole decreases expression ISO RGD:1557796 6480464 epoxiconazole results in decreased expression of ATP6AP2 mRNA CTD PMID:35436446 ethanol affects splicing ISO RGD:1557796 6480464 Ethanol affects the splicing of ATP6AP2 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1346001 6480464 Ethyl Methanesulfonate results in increased expression of ATP6AP2 mRNA CTD PMID:23649840 finasteride increases expression EXP 6480464 Finasteride results in increased expression of ATP6AP2 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ATP6AP2 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1557796 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP6AP2 mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:1346001 6480464 Formaldehyde results in increased expression of ATP6AP2 mRNA CTD PMID:23649840 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ATP6AP2 mRNA CTD PMID:33387578 glucose increases expression EXP 6480464 Glucose results in increased expression of ATP6AP2 mRNA, Glucose results in increased expression of ATP6AP2 protein CTD PMID:19861503 glucose multiple interactions EXP 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 mRNA], N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 protein] CTD PMID:19861503 isoprenaline multiple interactions EXP 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP6AP2 mRNA CTD PMID:30303030 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of ATP6AP2 mRNA CTD PMID:19483382 lead(0) decreases expression ISO RGD:1346001 6480464 Lead results in decreased expression of ATP6AP2 mRNA CTD PMID:19921347 lead(0) affects expression ISO RGD:1346001 6480464 Lead affects the expression of ATP6AP2 mRNA CTD PMID:28903495 lead(2+) decreases expression ISO RGD:1346001 6480464 Lead results in decreased expression of ATP6AP2 mRNA CTD PMID:19921347 lead(2+) affects expression ISO RGD:1346001 6480464 Lead affects the expression of ATP6AP2 mRNA CTD PMID:28903495 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of ATP6AP2 mRNA CTD PMID:24136188 methyl methanesulfonate increases expression ISO RGD:1346001 6480464 Methyl Methanesulfonate results in increased expression of ATP6AP2 mRNA CTD PMID:23649840 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of ATP6AP2 mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of ATP6AP2 mRNA CTD PMID:24136188 Nivalenol increases expression ISO RGD:1557796 6480464 nivalenol results in increased expression of ATP6AP2 mRNA CTD PMID:35016910 NS-398 multiple interactions EXP 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 mRNA], N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 protein] CTD PMID:19861503 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of ATP6AP2 mRNA CTD PMID:19483382 ozone multiple interactions ISO RGD:1346001 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP6AP2 mRNA more ... CTD PMID:32699268 paracetamol increases expression ISO RGD:1346001 6480464 Acetaminophen results in increased expression of ATP6AP2 mRNA CTD PMID:22230336 perfluorooctanoic acid decreases expression ISO RGD:1346001 6480464 perfluorooctanoic acid results in decreased expression of ATP6AP2 protein CTD PMID:26879310 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of ATP6AP2 mRNA CTD PMID:19483382 potassium chromate decreases expression ISO RGD:1346001 6480464 potassium chromate(VI) results in decreased expression of ATP6AP2 mRNA CTD PMID:22714537 rac-lactic acid decreases expression ISO RGD:1346001 6480464 Lactic Acid results in decreased expression of ATP6AP2 mRNA CTD PMID:30851411 silicon dioxide decreases expression ISO RGD:1346001 6480464 Silicon Dioxide analog results in decreased expression of ATP6AP2 mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:1557796 6480464 Silver results in decreased expression of ATP6AP2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1557796 6480464 Silver results in decreased expression of ATP6AP2 mRNA CTD PMID:27131904 streptozocin multiple interactions EXP 6480464 (3 more ... CTD PMID:18192338 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of ATP6AP2 mRNA, Streptozocin results in increased expression of ATP6AP2 protein CTD PMID:18192338 sunitinib increases expression ISO RGD:1346001 6480464 Sunitinib results in increased expression of ATP6AP2 mRNA CTD PMID:31533062 tetrachloromethane increases expression ISO RGD:1557796 6480464 Carbon Tetrachloride results in increased expression of ATP6AP2 mRNA CTD PMID:27339419 , PMID:31919559 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of ATP6AP2 protein CTD PMID:35544339 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of ATP6AP2 mRNA CTD PMID:19483382 trichostatin A affects expression ISO RGD:1346001 6480464 trichostatin A affects the expression of ATP6AP2 mRNA CTD PMID:28542535 valproic acid affects expression ISO RGD:1346001 6480464 Valproic Acid affects the expression of ATP6AP2 mRNA CTD PMID:25979313 valproic acid affects methylation ISO RGD:1346001 6480464 Valproic Acid affects the methylation of ATP6AP2 gene CTD PMID:29501571 valproic acid increases expression ISO RGD:1346001 6480464 Valproic Acid results in increased expression of ATP6AP2 mRNA CTD PMID:23179753 more ... valsartan multiple interactions EXP 6480464 Valsartan inhibits the reaction [Streptozocin results in increased expression of ATP6AP2 mRNA], Valsartan inhibits the reaction [Streptozocin results in increased expression of ATP6AP2 protein] CTD PMID:18192338 vanadium atom increases expression ISO RGD:1346001 6480464 Vanadium results in increased expression of ATP6AP2 mRNA CTD PMID:19000753 vanadium(0) increases expression ISO RGD:1346001 6480464 Vanadium results in increased expression of ATP6AP2 mRNA CTD PMID:19000753 vitamin E decreases expression ISO RGD:1346001 6480464 Vitamin E results in decreased expression of ATP6AP2 mRNA CTD PMID:19244175